HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Accepted manuscript (PDF) All Versions of this Article: JOE-08-0474v1 200/3/301    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nolan, L. Articles by Levy, A. Search for Related Content PubMed PubMed Citation Articles by Nolan, L. Articles by Levy, A.

L Nolan, Henry Wellcome Labs for Integrative Neuroscience & Endocrinology, Bristol University, Bristol, United Kingdom
A Levy, Henry Wellcome Labs for Integrative Neuroscience & Endocrinology, Bristol University, Bristol, BS1 3NY, United Kingdom

Correspondence: Andy Levy, Email: a.levy{at}bris.ac.uk

Abstract

Oestrogen is a powerful mitogen that is believed to exert a continuous, dose-dependent trophic stimulus at the anterior pituitary. This persistent mitotic effect contrasts with corticosterone and testosterone, changes in the levels of which induce only transient, self-limiting fluctuations in pituitary mitotic activity. To further define the putative long term trophic effects of oestrogen, we have accurately analysed the effects of 7 and 28 days oestrogen treatment on anterior pituitary mitotic activity in ovariectomized 10 week-old Wistar rats using both bromodeoxyuridine and timed colchicine-induced mitotic arrest.

An oestrogen dose-dependent increase in mitotic index was seen 7 days after the start of treatment as expected, representing an acceleration in gross mitotic activity from 1.7%/day in ovariectomized animals in the absence of any oestrogen replacement to 3.7%/day in the presence of a pharmacological dose of oestrogen (50mcg/rat.day: approximately 230mcg/kg.day). Despite continued exposure to high dose oestrogen and persistence of the increase in pituitary wet weight, the increase in mitotic index was unexpectedly not sustained. After 28 days of high dose oestrogen treatment, anterior pituitary mitotic index and bromodeoxyuridine-labelling index were not significantly different from baseline.

Although a powerful pituitary mitogen in the short term, responsible, presumably, for increased trophic variability in oestrus cycling females, these data indicate that in keeping with other trophic stimuli to the pituitary and in contrast to much established dogma, the mitotic response to longer-term high dose oestrogen exposure is transient and is not the driver of persistent pituitary growth, at least in female Wistar rats.